These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26957485)

  • 21. "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue.
    Baudo F
    Intern Emerg Med; 2006; 1(2):94-5. PubMed ID: 17111780
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periprocedural bridging management of anticoagulation.
    Wysokinski WE; McBane RD
    Circulation; 2012 Jul; 126(4):486-90. PubMed ID: 22825410
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
    Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
    Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Perioperative heparin bridging is rarely indicated].
    Nielsen JD; Hermann TS; Husum D; Osbak PS
    Ugeskr Laeger; 2021 Nov; 183(47):. PubMed ID: 34851259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 30. Bridging therapy and oral anticoagulation: current and future prospects.
    Spyropoulos AC
    Curr Opin Hematol; 2010 Sep; 17(5):444-9. PubMed ID: 20613508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bridging anticoagulation].
    Schellong SM; Halbritter K; Haas S
    Chirurg; 2007 Feb; 78(2):125-6, 128-32. PubMed ID: 17252252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopenia.
    Pendleton RC; Rodgers GM; Hull RD
    Clin Chest Med; 2010 Dec; 31(4):691-706. PubMed ID: 21047576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
    Hirsh J
    Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.
    Mannucci C; Douketis JD
    Intern Emerg Med; 2006; 1(2):96-104. PubMed ID: 17111781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of deep vein thrombosis. First choice treatments.
    Prescrire Int; 2015 Sep; 24(163):217-9. PubMed ID: 26417635
    [No Abstract]   [Full Text] [Related]  

  • 36. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
    Dempfle CE; Borggrefe M
    Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?
    Schulman S
    Haemostasis; 1998; 28 Suppl 3():17-21. PubMed ID: 10069758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative reduction of the warfarin dose.
    Milligan PE; Banet GA; Gage BF
    Am J Med; 2003 Dec; 115(9):741-2. PubMed ID: 14693332
    [No Abstract]   [Full Text] [Related]  

  • 39. Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study.
    Eljilany I; Elarref M; Shallik N; Elzouki AN; Mohammed A; Shoman B; Ibrahim S; Carr C; Al-Badriyeh D; Cavallari LH; Elewa H
    Curr Probl Cardiol; 2021 Jun; 46(6):100816. PubMed ID: 33721568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.